India, Aug. 26 -- Today's top gainers in the biotech and healthcare space include Summit Therapeutics, following positive Phase III HARMONi trial data; Celularity, despite a Nasdaq compliance notice; Biodesix, on strong quarterly growth; Cardiol Therapeutics, after narrowing its quarterly loss; and Edesa Biotech, following its proposed public offering.
Read on...
SMMT Jumps 7% As Ivonescimab Delivers Significant PFS Benefit
Summit Therapeutics Inc. (SMMT) shares rose 7% after Phase III HARMONi trial results showed a significant progression-free survival benefit for ivonescimab plus chemotherapy in EGFR-mutated advanced non-small cell lung cancer.
Median PFS was 6.8 months versus 4.4 months for placebo plus chemotherapy, with a hazard ra...